Apellis Pharmaceuticals Inc Archives

Home Tags Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals Inc (NASDAQ:APLS) Insider Trading Activity – CEO Sold 5,000...

ME Staff - November 19, 2019

Apellis Pharmaceuticals Inc (NASDAQ:APLS) Insider Trading Activity – COO Sold 42,460...

ME Staff - September 27, 2019

Apellis Pharmaceuticals Inc (NASDAQ:APLS) gets upgraded to Overweight by JPMorgan Chase...

ME Staff - July 12, 2019

Apellis Pharmaceuticals Inc (NASDAQ:APLS) gets downgraded to Neutral by JPMorgan Chase...

ME Staff - January 23, 2019

Apellis Pharmaceuticals Inc (NASDAQ:APLS) had its Buy rating reiterated by Cantor...

ME Staff - December 20, 2018

Apellis Pharmaceuticals Inc (NASDAQ:APLS) price target raised to $40.00 by Citigroup

ME Staff - December 6, 2018

Apellis Pharmaceuticals Inc (NASDAQ:APLS) price target set to $53.00 by Cantor...

ME Staff - December 3, 2018

Apellis Pharmaceuticals Inc (NASDAQ:APLS) gets upgraded to Buy by B. Riley...

ME Staff - July 30, 2018

/* */

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

September 18, 2023

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

September 11, 2023

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

August 21, 2023

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals Inc (NASDAQ:APLS) Insider Trading Activity – CEO Sold 5,000...

Apellis Pharmaceuticals Inc (NASDAQ:APLS) Insider Trading Activity – COO Sold 42,460...

Apellis Pharmaceuticals Inc (NASDAQ:APLS) gets upgraded to Overweight by JPMorgan Chase...

Apellis Pharmaceuticals Inc (NASDAQ:APLS) gets downgraded to Neutral by JPMorgan Chase...

Apellis Pharmaceuticals Inc (NASDAQ:APLS) had its Buy rating reiterated by Cantor...

Apellis Pharmaceuticals Inc (NASDAQ:APLS) price target raised to $40.00 by Citigroup

Apellis Pharmaceuticals Inc (NASDAQ:APLS) price target set to $53.00 by Cantor...

Apellis Pharmaceuticals Inc (NASDAQ:APLS) gets upgraded to Buy by B. Riley...

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY